Cargando…
Sarcopenia in CKD: a roadmap from basic pathogenetic mechanisms to clinical trials
Sarcopenia and frailty are recognized as key risk factors for adverse outcomes in patients on renal replacement therapy or with non-dialysis chronic kidney disease (CKD). However, there is still debate about their pathogenesis and, thus, about the best therapeutic approaches, as well as the impact o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366131/ https://www.ncbi.nlm.nih.gov/pubmed/30746137 http://dx.doi.org/10.1093/ckj/sfz001 |